Recently, Tsai et al. [80] demonstrated that miR-196a/b expression in the serum of GC patients could be more sensitive and specific for GC diagnosis than CA 19-9 (carcinoembryonic antigen 19-9) or CEA (carbohydrate antigen). The gene discussed is CEACAM5; the disease is gastric cancer.